Literature DB >> 31852408

Pharmacological treatment of stable COPD: need for a simplified approach.

G Hillas1, A Papaporfyriou2, K Dimakou1, A I Papaioannou2.   

Abstract

Chronic obstructive pulmonary disease (COPD) is one of the most common diseases worldwide. Although different guidelines regarding therapeutic algorithms exist, the most widely adopted approach is the one suggested by the Global Initiative in Chronic Obstructive Lung Disease in which patients are stratified according to their dyspnea severity and their exacerbation history during the previous year. This combined assessment of COPD, which takes into consideration all aforementioned characteristics of COPD patients as well as the number of blood eosinophils, results in a proposed therapeutic algorithm which is complex and hard to memorize. This complexity is probable one of the causes that most health care professionals are not adherent to the guidelines when treating COPD patients. Here, we propose a simplified therapeutic algorithm for the treatment of COPD patients taking into consideration the current evidence on the use of bronchodilators and inhaled corticosteroids.

Entities:  

Keywords:  Chronic Obstructive Pulmonary Disease; acute exacerbations of COPD; blood eosinophils; dual bronchodilation; inhaled corticosteroids; long acting bronchodilators

Mesh:

Substances:

Year:  2020        PMID: 31852408     DOI: 10.1080/00325481.2019.1706996

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  2 in total

Review 1.  Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions.

Authors:  Evangelia Fouka; Andriana I Papaioannou; Georgios Hillas; Paschalis Steiropoulos
Journal:  J Pers Med       Date:  2022-04-28

2.  The CT pulmonary vascular parameters and disease severity in COPD patients on acute exacerbation: a correlation analysis.

Authors:  Tao Yang; Chihua Chen; Zhongyuanlong Chen
Journal:  BMC Pulm Med       Date:  2021-01-20       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.